What role does NutriCare | INFINITY DNA-Test play in blood sugar?

The NutriCare | INFINITY DNA-Test analyzes genetic variants linked to glucose metabolism, such as those in TCF7L2, GCK, or PPARG. However, the scientific evidence for such tests is limited: individual variant effect sizes on blood sugar are typically small (odds ratios <1.2) and are strongly overshadowed by diet, exercise, and lifestyle. The test cannot replace medical diagnosis; it can only offer hints about possible sensitivities. In practice, the benefit is often overestimated – many claimed associations come from low-powered association studies or purely mechanistic models. A direct blood sugar measurement (e.g., fasting glucose, HbA1c) is far more relevant for assessing current metabolic status. Moreover, independent clinical studies validating this specific test are lacking. Consumers should be wary of exaggerated marketing claims and consult a doctor or dietitian before making dietary or supplement changes. Overall, the test plays at best a complementary role – real blood sugar control requires measurable biomarkers and personalized adjustments.